Background: The purpose of the present study was to evaluate the psychometric properties (validity and reliability) of the Persian version of the Sustained Auditory Attention Capacity Test in children with attention deficit hyperactivity disorder.
Methods: The Persian version of the Sustained Auditory Attention Capacity Test was constructed to assess sustained auditory attention using the method provided by Feniman and colleagues (2007). In this test, comments were provided to assess the child's attentional deficit by determining inattention and impulsiveness error, the total scores of the sustained auditory attention capacity test and attention span reduction index. In the present study for determining the validity and reliability of in both Rey Auditory Verbal Learning test and the Persian version of the Sustained Auditory Attention Capacity Test (SAACT), 46 normal children and 41 children with Attention Deficit Hyperactivity (ADHD), all right-handed and aged between 7 and 11 of both genders, were evaluated.
Results: In determining convergent validity, a negative significant correlation was found between the three parts of the Rey Auditory Verbal Learning test (first, fifth, and immediate recall) and all indicators of the SAACT except attention span reduction. By comparing the test scores between the normal and ADHD groups, discriminant validity analysis showed significant differences in all indicators of the test except for attention span reduction (p< 0.001).
Conclusion: The Persian version of the Sustained Auditory Attention Capacity test has good validity and reliability, that matches other reliable tests, and it can be used for the identification of children with attention deficits and if they suspected to have Attention Deficit Hyperactivity Disorder.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153530 | PMC |
Codas
March 2025
Universidade Federal de Santa Maria - UFSM - Santa Maria (RS), Brasil.
Purpose: to measure the effect of Brief Computerized Auditory Training (Brief-CAT) on behavioral auditory and speech skills in children with Speech Sound Disorder (SSD).
Methods: 14 children, aged 6 and 9, diagnosed with SSD participated. All children presented one or more altered auditory skills in the behavioral assessment of Central Auditory Processing (CAP).
Ear Hear
March 2025
Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.
Objectives: Age-related hearing loss, the predominant global cause of hearing loss in middle-aged and older adults, presents a significant health and social problem, particularly affecting speech understanding. Beyond the auditory system, cognitive functions play a crucial role in speech understanding, especially in noisy environments. Although visual cognitive testing is commonly used as an intriguing alternative to mitigate the potential adverse effects of hearing loss on the perception of auditory test items, its efficacy within a hearing-related context is questionable due to construct differences.
View Article and Find Full Text PDFJ Voice
March 2025
École d'orthophonie et d'audiologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada.
Objectives: This study aimed to evaluate the inter- and intra-rater reliability of consensus auditory-perceptual evaluation of voice (CAPE-V) auditory-perceptual ratings and explore task-specific differences (sustained vowels versus sentences) in ratings and reliability.
Study Design: Cross-sectional reliability study using a curated subset of dysphonic voice samples (PVQD).
Methods: Thirty voice samples representing varying dysphonia severities were selected from the Perceptual Voice Qualities Database.
J Speech Lang Hear Res
February 2025
Department of Surgery, University of Wisconsin-Madison.
Objective: The objective of this study was to examine the relationship between laryngeal aerodynamics, acoustics, and hypernasality in children with cleft palate with or without lip (CP ± L).
Method: This study used a prospectively performed cross-sectional design. Fifty-six children between the ages of 6 and 17 years with CP ± L participated (= 11.
Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder caused by pathogenic variants in the gene encoding iduronate-2-sulfatase (IDS), which hydrolyzes sulfate groups in dermatan sulfate and heparan sulfate. The current treatment for MPS II includes enzyme replacement therapy and hematopoietic stem cell transplantation (HSCT). Both therapies have shown limited penetration through the blood-brain barrier.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!